#LCSM Chat Topic 2019-02-07: Is it worth the drive?

Unfortunately, you just got diagnosed with cancer.  You and your family are desperately trying to figure out where to go and which doctor to see.  But how far are you willing to go?  Can you be more confident in your diagnosis, decrease your complications, and improve your chances of survival if you drive a little farther, past your local hospital, to a specialized center that treats a higher volume of cancer patients?  What would it take for you, the patient, to go that extra distance? Seminal surgical studies have described a “volume… Read More

#LCSM Chat 2019/01/06–Immunotherapy: What Patients Need To Know

It’s a new year, and #LCSM Chat is transitioning to monthly chats.  Our first chat is a collaborative chat across all cancer hashtag communities titled “Immunotherapy: What Patients Need to Know.” The discussion will cover all types of immunotherapy currently approved for treatment of any cancer. Chat moderator Janet Freeman-Daily (@JFreemanDaily) will be joined by special guest Lisa Rezende (@LisaRezende1), a biology educator (Assistant Professor of Practice) on the Molecular and Cellular Biology faculty at the University of Arizona.  Lisa is also a long-term volunteer cancer advocate with FORCE (Facing Our Risk of… Read More

#LCSM Chat Topic 10/04/2018: Highlights from #WCLC2018

After a summer hiatus, #LCSM Chat is returning to Twitter!  Our first chat of the fall will be on Thursday, October 04, at 5pm Pacific Time (8 pm Eastern).  We will be reviewing key presentations from the IASLC 19th World Conference on Lung Cancer (#WCLC2018) held September 23-26 in Toronto, Canada.  Our special guests for this chat will be the Communications Team from the International Association for the Study of Lung Cancer (IASLC), the organizers of WCLC, and our moderator will be Janet Freeman-Daily (@JFreemanDaily). WCLC abstracts may be oral presentations (20… Read More